Johnson & Johnson partners on spine, trauma robot in China

Laura Dyrda -   Print  |

Johnson & Johnson Medical Shanghai entered into a co-marketing agreement and research and development agreement with the orthopedic robotics market leader in China, Tinavi. 


Four key notes:

1. The collaboration allows Johnson & Johnson Medical Device's orthopedics business, DePuy Synthes, to bring Tinavi's spinal and trauma robotic solution to the China orthopedics implant market.

2. Tinavi's robotic planform has approval from the National Medical Products Administration in China and includes a robotic arm, intraoperative planning interface and integrated navigation with intraoperative 3D imaging.

3. This agreement aligns with Johnson & Johnson's goal to build a connected environment with technologies to enhance surgical performance, education and monitoring.

4. Tinavi is the only arm-based robotic technology that has multiple indications approved in China.

More articles on orthopedic devices:
Stryker closes $500M acquisition of Mobius Imaging, Cardan Robotics – 4 things to know
Texas hospital to build $40M orthopedic center, recruit up to 40 physicians
Life Spine, execs to settle FCA allegations for nearly $6M

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers